Notice: This CMS-approved document has been submitted - Philips ...

Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...

healthcare.philips.com
from healthcare.philips.com More from this publisher
19.02.2013 Views

CMS-1403-FC being taken, the kinds and number of small entities the rule affects, and an explanation of any meaningful options that achieve the objectives with less significant adverse economic impact on the small entities. For purposes of the RFA, physicians, NPPs, and suppliers including IDTFs are considered small businesses if they generate revenues of $7 million or less based on SBA size standards. Approximately 95 percent of physicians are considered to be small entities. There are about 980,000 physicians, other practitioners, and medical suppliers that receive Medicare payment under the PFS. For purposes of the RFA, approximately 85 percent of suppliers of durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) are considered small businesses according to the Small Business Administration’s (SBA) size standards. We estimate that approximately 66,000 entities bill Medicare for DMEPOS each year. Total annual estimated Medicare revenues for DMEPOS suppliers are approximately $10.8 billion in 2007 for which $8.3 billion was for fee-for-service and $2.5 billion was for managed care. However the therapeutic shoe, oxygen and oxygen equipment, and low vision aids provisions in this rule do not have a significant economic impact on a substantial number of small entities. In the case of therapeutic 1032

CMS-1403-FC shoes, the regulation is being updated to reflect the fact that fee schedules were implemented on January 1, 2005, in accordance with the requirements of MMA section 627. Since the fees themselves are not impacted by this change, suppliers are likewise not impacted by this change. In the 1033 case of oxygen and oxygen equipment, as explained in section S.9. below, it is difficult to estimate the impact of section 144(b) of the MIPPA on small entities and oxygen and oxygen equipment suppliers in general. Nevertheless, we do believe that the net impact on small entities and other suppliers of oxygen and oxygen equipment will be positive rather than negative. This is based on the fact that this change allows suppliers to retain ownership of oxygen equipment in all cases when it is no longer needed by the beneficiary. Prior to this change, suppliers were required to relinquish ownership of oxygen equipment after 36 continuous rental months. While suppliers will be required to continue furnishing the equipment after the 36-month rental period for up to 2 additional years in some cases until the 5 year reasonable useful lifetime of the equipment ends, they will retain ownership of equipment when it is no longer needed and can furnish the equipment to other patients. Although suppliers will not be paid for non- routine maintenance or repair of oxygen equipment they own and furnish to Medicare beneficiaries, the equipment itself is very dependable and requires very little maintenance and servicing, so this change should not significantly impact

<strong>CMS</strong>-1403-FC<br />

being taken, the kinds and number of small entities the<br />

rule affects, and an explanation of any meaningful options<br />

that achieve the objectives with less significant adverse<br />

economic impact on the small entities.<br />

For purposes of the RFA, physicians, NPPs, and<br />

suppliers including IDTFs are considered small businesses<br />

if they generate revenues of $7 million or less based on<br />

SBA size standards. Approximately 95 percent of physicians<br />

are considered to be small entities. There are about<br />

980,000 physicians, other practitioners, and medical<br />

suppliers that receive Medicare payment under the PFS.<br />

For purposes of the RFA, approximately 85 percent of<br />

suppliers of durable medical equipment, prosthetics,<br />

orthotics and supplies (DMEPOS) are considered small<br />

businesses according to the Small Business Administration’s<br />

(SBA) size standards. We estimate that approximately<br />

66,000 entities bill Medicare for DMEPOS each year. Total<br />

annual estimated Medicare revenues for DMEPOS suppliers are<br />

approximately $10.8 billion in 2007 for which $8.3 billion<br />

was for fee-for-service and $2.5 billion was for managed<br />

care. However the therapeutic shoe, oxygen and oxygen<br />

equipment, and low vision aids provisions in this rule do<br />

not have a significant economic impact on a substantial<br />

number of small entities. In the case of therapeutic<br />

1032

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!